Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome
John P Fezza Center for Sight, Sarasota, FL, USA Purpose: A new cross-linked hyaluronic acid (xlHA) gel occlusive device was assessed for safety and efficacy in the treatment of dry eyes.Methods: This was an institutional review board-approved, single-site, open-label, prospective study to assess...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/cross-linked-hyaluronic-acid-gel-occlusive-device-for-the-treatment-of-peer-reviewed-article-OPTH |